IF a sequential "prime-then-push" protocol — rapamycin (14 ppm in encapsulated chow, orally, 8 weeks continuous) followed by hyperbaric oxygen therapy (HBOT; 2.0 ATA, 90 min/session, 5×/week, 60 sessions) — is administered to aged male C57BL/6J mice (22–24 months),

THEN epigenetic clock age (measured via validated murine DNA methylation arrays across blood, liver, and lung) will be reversed by ≥30% more than either intervention alone, senescent cell burden (p16^INK4a^, p21, SA-β-gal) will be reduced by ≥40% beyond monotherapy, and survival-weighted healthspan metrics (grip strength, rotarod, body composition) will be significantly improved compared to either monotherapy arm,

BECAUSE the following step-by-step causal chain operates:

1. Rapamycin inhibits mTORC1 in senescent cells, suppressing the mTOR-driven pro-survival and SASP-maintenance signaling that normally prevents senescent cell apoptosis — (mTOR perturbation reduced ROS and γH2AX foci in senescent cells via two independent siRNAs)[https://doi.org/10.15252/embj.201592862], establishing mTOR suppression as a vulnerability-inducing step in senescent cells.

2. Rapamycin restores mitophagy in senescent cells, which were otherwise characterized by impaired mitophagy — (senescent cells displayed impaired mitophagy; rapamycin enhanced mitophagy)[https://doi.org/10.7554/elife.75492]. This paradoxically reduces the mitochondrial ROS buffering reservoir, lowering the oxidative stress threshold required to trigger senescent cell apoptosis.

3. Aberrant mTOR activation drives mitochondrial ROS accumulation in senescent and aged tissues — (activation of mTOR/p70S6K occurs in aged tissues and senescent cells; mitochondrial dysfunction and mitochondrial ROS support a model of mTOR-driven senescence maintenance)[https://doi.org/10.1016/j.exger.2014.11.004]. Rapamycin-mediated mTOR suppression therefore de-energizes the mitochondrial ROS apparatus that underpins anti-apoptotic resistance.

4. HBOT (2.0 ATA, 90 min/session) delivers pulsatile supraphysiological oxygen bursts that generate transient, non-lethal ROS waves in healthy cells but reach apoptotic thresholds selectively in senescent cells whose mitochondrial ROS-buffering capacity has been pre-depleted by rapamycin-enhanced mitophagy. [SPECULATIVE — direct in vivo measurement of differential ROS sensitivity between rapamycin-primed senescent vs. non-senescent cells under hyperoxia not yet performed.]

5. The hyperoxic-hypoxic paradox creates HIF-1α oscillations following HBOT sessions — intermittent hyperoxia followed by normoxia induces HIF-1α re-activation — which in healthy cells drives angiogenic repair and epigenetic remodeling (described in the Evidence Set Literature Task Output on the "hyperoxic-hypoxic paradox"). In cells where mTOR has been suppressed by rapamycin, HIF-1α activity is decoupled from mTORC1-driven translation, potentially amplifying pro-repair transcriptional programs. [SPECULATIVE — the specific i...

SENS category: GlycoSENS

Key references: • doi.org/10.15252/embj.201592862], • doi.org/10.7554/elife.75492]. • doi.org/10.1016/j.exger.2014.11.004]. • doi.org/10.1093/gerona/glu241]. • doi.org/10.1007/s11357-020-00180-6]